Technical Analysis for ABT - Abbott Laboratories
|Grade||Last Price||% Change||Price Change|
ABT closed down 0.39 percent on Friday, June 23, 2017, on 1.32 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Trend Table & Recent Alerts
|See historical ABT trend table...|
|Date||Alert Name||Type||% Chg|
|Jun 23||NR7||Range Contraction||0.00%|
|Jun 22||New 52 Week High||Bullish||-0.39%|
|Jun 21||Slingshot Bullish||Bullish Swing Setup||1.05%|
|Jun 20||New 52 Week High||Bullish||0.64%|
|Jun 20||Shooting Star Candlestick||Bearish||0.64%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Is ABT a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ABT news...
|52 Week High||49.59|
|52 Week Low||36.8304|
|200-Day Moving Average||42.1438|
|50-Day Moving Average||45.1546|
|20-Day Moving Average||47.235|
|10-Day Moving Average||48.318|
|Average True Range||0.6455|
|Chandelier Exit (Long, 3 ATRs)||47.6535|
|Chandelier Exit (Short, 3 ATRs)||45.3365|
|Upper Bollinger Band||49.8397|
|Lower Bollinger Band||44.6303|
|Percent B (%b)||0.85|
|MACD Signal Line||1.0479|